Back to Treatments

Treatment

Vemurafenib + Cobimetinib

1
Conditions
8
Trials
5,000
Participants
38%
Average Safety

Condition Evidence

Malignant skin melanoma

8 trials · 5,000 participants

90% effectiveness · 38% safety
Vemurafenib + Cobimetinib | DFDA